Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: Results of the adalimumab in Canadian subjects with moderate to severe Crohn's diseaSe (ACCESS) trial

Remo Panaccione, Edward V. Loftus, David Binion, Kevin McHugh, Shamsul Alam, Naijun Chen, Benoit̂ Gueŕette, Parvez Mulani, Jingdong Chao

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: Results of the adalimumab in Canadian subjects with moderate to severe Crohn's diseaSe (ACCESS) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences